A phase I single‑dose trial to evaluate safety, tolerability and pharmacokinetics (PK) of Gemcabene in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Gemcabene (Primary)
- Indications Hypercholesterolaemia; Hyperlipoproteinaemia; Hypertension; Hypertriglyceridaemia; Non-alcoholic steatohepatitis; Osteoarthritis
- Focus Adverse reactions; Pharmacokinetics
- 20 Apr 2017 New trial record